Recap: Integra Lifesciences Q4 Earnings - Integra Lifesciences (NASDAQ:IART)

Integra Lifesciences IART reported its Q4 earnings results on Wednesday, February 28, 2024 at 06:00 AM.

Here's what investors need to know about the announcement.

Integra Lifesciences missed estimated earnings by -1.0%, reporting an EPS of $0.89 versus an estimate of $0.9.

Revenue was down $983 thousand from the same period last year.

Last quarter the company missed on EPS by $0.02 which was followed by a 1.0% increase in the share price the next day.

Here's a look at Integra Lifesciences's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	0.78	0.57	0.74	0.90
EPS Actual	0.76	0.71	0.74	0.94
Revenue Estimate	387.12M	374.07M	373.21M	397.95M
Revenue Actual	382.42M	381.30M	380.85M	398.02M

To track all earnings releases for Integra Lifesciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.